Anti-TB Drugs Flashcards
Ethambutol
first line drug, EMPIRICAL TX
MOA: inhibits mycobacterial arabinosyl transferases (embCAB operon) –> inhibits synthesis of cell wall
resistance: mutations in embB gene
toxicity: retrobulbar neuritis (loss of acuity, red-green color blindness)
Isoniazid
first line drug, EMPIRICAL TX
MOA: inhibits synthesis of mycolic acids (cell wall)
forms complex w/ AcpM + KasA
activated by KatG
resistance: mutations in KasA, KatG
toxicity: hepatitis, peripheral neuropathy (prevented w/ pyridoxine admin)
Pyrazinamide
first line drug, EMPIRICAL TX
MOA unknown
resistance: mutations in pncA
toxicity: hepatotoxicity, hyperuricemia (joint pain)
Rifampin
first line drug, EMPIRICAL TX
MOA: bind to DNA-dep RNA polymerase –> inhibits RNA synthesis (bactericidal)
STRONG P450 inducer (caution in HIV pts w/ PIs or NNRTIs)
resistance: mutations in rpoB gene
toxicity: flu-like sx if admin for less than 2 wks, harmless orange-red urine
prophylaxis for H influenzae type B
Streptomycin
first line drug, EMPIRICAL TX
aminoglycoside, ONLY IV/IM
MOA: binds 30S –> irreversible inhibitor of protein synthesis
active against EXTRAcellular mycobacterium
effective against Myco TB, MAC, Myco Kansii
resistance: mutations in rpsL/rrs gene
toxicity: ototoxicity, nephrotoxicity
RELATIVE contraind in pregnancy
Amikacin
second line drug
similar to streptomycin
toxicity: hearing loss
Kanamycin
second line drug
similar to streptpmycin
toxicity: hearing loss
Aminosalicylic acid
second line drug
folate synthesis antagonist
toxicity: SEVERE HS rxns (not usually used d/t this)
Capreomycin
second line drug
peptide protein synthesis inhibitor
IM
toxicity: sterile abscess at injection site, ototoxic
Cycloserine
second line drug
inhibitor of cell wall synthesis
Ethionamide
second line drug
similar to INH, low level cross-resistance w/ INH
blocks synthesis of mycolic acids
toxicity: hepatotoxicity, neurologic effects (reversed w/ pyridoxine)
Rifabutin
second line
substrate and inducer of CYP450 enzymes
resistance: mutations in rpoB
rifapentine
second line drug
long acting analog of rifampin
cross-reactive w/ RIF
latent TB infxn (LTBI)
INH for 9 mo